Lilly Reports Solid First-Quart...( Cost of sales 1111....)

Cost of sales 1,111.3 938.4 18 %

Research and development 877.1 846.2 4 %

Marketing, selling and

administrative 1,550.5 1372.7 13 %

Acquired in-process research

and development 87.0 328.5 N/M

Asset impairments,

restructuring and other

special charges 145.7 123.0 18 %

--------- ---------

Operating income 1,036.0 690.0 50 %

Net interest income

(expense) (3.5) (65.5)

Joint-venture income 0.0 0.0

Net other income 23.8 82.3

--------- ---------

Other income 20.3 16.8

Income before income taxes 1,056.3 706.8 49 %

Income taxes (8.0) 209.6 N/M

--------- ---------

Net income $ 1,064.3 $ 497.2 114 %

--------- ---------

Earnings per share -

basic $ 0.97 $ 0.46 111 %

--------- ---------

Earnings per share -

diluted $ 0.97 $ 0.46 111 %

--------- ---------

Dividends paid per share $ 0.47 $ 0.425 11 %

Weighted-average shares

outstanding (thousands) -

basic 1,093,866 1,089,732

Weighted-average shares

outstanding (thousands) -

diluted 1,094,056 1,089,879

N/M - not meaningful

(a) In accordance with generally accepted accounting principles (GAAP),

the 2007 financial statement has be
'/>"/>